Dexcom shares plummet almost 40% after company misses on revenue, lowers guidance
The Dexcom logo is seen on a smartphone screen and in the background.Pavlo Gonchar | SOPA Images | Lightrocket | ...
Tag: Health care industry
Dexcom shares plunge more than 40% for worst day on record
Dexcom shares sank more than 40% on Friday, their steepest decline ever, after the diabetes management company reported disappointing revenue ...
Inside the $43 million Veterans Affairs simulation hospital where doctors are piloting new tech
An operating room at SimVETCourtesy: SimVETInside a sprawling $43 million Veterans Affairs facility equipped with operating rooms, intensive care units ...
Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says
Federal Trade Commission Chair Lina Khan testifies during a hearing of the House Appropriations Subcommittee on Financial Services and General ...
Musk says next Neuralink brain implant expected soon, despite issues with the first patient
Jonathan Raa | Nurphoto | Getty ImagesElon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its ...
This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks.It is behind the GLP-1, Obesity & Cardiometabolic ...
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
Kena Betancur | Corbis News | Getty ImagesPfizer had a "phenomenal" first quarter — and Wall Street took notice, CEO ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
Zoom In IconArrows pointing outwardsMerck's new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck's new vaccine ...
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment ...
